Lara Milane

3.2k total citations · 3 hit papers
21 papers, 2.5k citations indexed

About

Lara Milane is a scholar working on Molecular Biology, Biomaterials and Cancer Research. According to data from OpenAlex, Lara Milane has authored 21 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Biomaterials and 6 papers in Cancer Research. Recurrent topics in Lara Milane's work include Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Lara Milane is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Lara Milane collaborates with scholars based in United States, Bangladesh and Puerto Rico. Lara Milane's co-authors include Mansoor M. Amiji, George Mattheolabakis, Zhenfeng Duan, Amit Singh, Amit Singh, Megha Suresh, Angela L. Nocera, Srujan Gandham, Alan Zimmerman and Alexander R. Ivanov and has published in prestigious journals such as ACS Nano, PLoS ONE and Journal of Controlled Release.

In The Last Decade

Lara Milane

21 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome mediated communication within the tumor microenvironment

2015 585 citations Lara Milane, Amit Singh et al. Journal of Controlled Release profile →
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine

2015 454 citations George Mattheolabakis, Lara Milane et al. Journal of drug targeting profile →
Technologies and Standardization in Research on Extracellular Vesicles

2020 361 citations Srujan Gandham, Angela L. Nocera et al. Trends in biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lara Milane United States	15	1.6k	772	602	600	306	21	2.5k
George Mattheolabakis United States	23	1.5k 0.9×	722 0.9×	685 1.1×	574 1.0×	312 1.0×	58	2.5k
Pierre Danhier Belgium	21	1.2k 0.7×	999 1.3×	460 0.8×	563 0.9×	294 1.0×	39	2.4k
Chalet Tan United States	26	1.2k 0.7×	507 0.7×	336 0.6×	384 0.6×	351 1.1×	47	2.3k
Peng Sun China	28	1.3k 0.8×	683 0.9×	266 0.4×	392 0.7×	350 1.1×	114	2.5k
Alberto Fernández‐Medarde Spain	15	1.6k 1.0×	303 0.4×	641 1.1×	591 1.0×	569 1.9×	31	2.8k
Yuan Fan China	14	1.3k 0.8×	347 0.4×	874 1.5×	741 1.2×	274 0.9×	29	2.3k
Fabio Pastorino Italy	36	2.1k 1.3×	652 0.8×	614 1.0×	462 0.8×	803 2.6×	90	3.5k
Dong Xu China	20	1.1k 0.6×	637 0.8×	407 0.7×	394 0.7×	257 0.8×	53	1.8k
Xiaoping Qian China	31	1.4k 0.9×	395 0.5×	797 1.3×	559 0.9×	710 2.3×	124	2.9k
Lixia Yu China	33	1.7k 1.1×	613 0.8×	752 1.2×	688 1.1×	859 2.8×	145	3.3k

Countries citing papers authored by Lara Milane

Since Specialization

Citations

This map shows the geographic impact of Lara Milane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Milane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Milane more than expected).

Fields of papers citing papers by Lara Milane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Milane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Milane. The network helps show where Lara Milane may publish in the future.

Co-authorship network of co-authors of Lara Milane

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Milane. A scholar is included among the top collaborators of Lara Milane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Milane. Lara Milane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matoba, Yusuke, et al.. (2024). High-Grade Endometrial Cancer: Molecular Subtypes, Current Challenges, and Treatment Options. Reproductive Sciences. 31(9). 2541–2559. 4 indexed citations

Milane, Lara, et al.. (2023). Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer. Journal of Controlled Release. 363. 435–451. 9 indexed citations

Milane, Lara, et al.. (2023). Lessons learned from the SARS-CoV-2 pandemic; from nucleic acid nanomedicines, to clinical trials, herd immunity, and the vaccination divide. Expert Opinion on Drug Delivery. 20(4). 489–506. 1 indexed citations

Milane, Lara, et al.. (2021). Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines. Nanomedicine Nanotechnology Biology and Medicine. 37. 102422–102422. 22 indexed citations

Milane, Lara & Mansoor M. Amiji. (2021). Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine. Drug Delivery and Translational Research. 11(4). 1309–1315. 88 indexed citations

Milane, Lara, et al.. (2021). Organelle and Molecular Targeting. 5 indexed citations

Gandham, Srujan, Angela L. Nocera, Lara Milane, et al.. (2020). Technologies and Standardization in Research on Extracellular Vesicles. Trends in biotechnology. 38(10). 1066–1098. 361 indexed citations breakdown →

Milane, Lara, et al.. (2019). Genetic and epigenetic strategies for advancing ovarian cancer immunotherapy. Expert Opinion on Biological Therapy. 19(6). 547–560. 6 indexed citations

Milane, Lara, Amit Singh, George Mattheolabakis, Megha Suresh, & Mansoor M. Amiji. (2015). Exosome mediated communication within the tumor microenvironment. Journal of Controlled Release. 219. 278–294. 585 indexed citations breakdown →

10.

Milane, Lara, Malav Trivedi, Amit Singh, Meghna Talekar, & Mansoor M. Amiji. (2015). Mitochondrial biology, targets, and drug delivery. Journal of Controlled Release. 207. 40–58. 127 indexed citations

11.

Gao, Yan, Jacson Shen, Lara Milane, et al.. (2015). Targeted Cancer Therapy; Nanotechnology Approaches for Overcoming Drug Resistance. Current Medicinal Chemistry. 22(11). 1335–1347. 25 indexed citations

12.

Mattheolabakis, George, Lara Milane, Amit Singh, & Mansoor M. Amiji. (2015). Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. Journal of drug targeting. 23(7-8). 605–618. 454 indexed citations breakdown →

13.

Yang, Xiaoqian, Arun K. Iyer, Amit Singh, et al.. (2014). Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer. Pharmaceutical Research. 32(6). 2097–2109. 69 indexed citations

14.

Milane, Lara, Zhenfeng Duan, & Mansoor M. Amiji. (2011). Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning. Cancer Cell International. 11(1). 3–3. 97 indexed citations

15.

Milane, Lara, Zhenfeng Duan, & Mansoor M. Amiji. (2011). Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant Cancer. PLoS ONE. 6(9). e24075–e24075. 78 indexed citations

16.

Milane, Lara, Shanthi Ganesh, Shruti Shah, Zhenfeng Duan, & Mansoor M. Amiji. (2011). Multi-modal strategies for overcoming tumor drug resistance: Hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology. Journal of Controlled Release. 155(2). 237–247. 111 indexed citations

17.

Milane, Lara, Zhenfeng Duan, & Mansoor M. Amiji. (2011). Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer. Nanomedicine Nanotechnology Biology and Medicine. 7(4). 435–444. 87 indexed citations

18.

Susa, Michiro, Arun K. Iyer, Edwin Choy, et al.. (2010). Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma. PLoS ONE. 5(5). e10764–e10764. 125 indexed citations

19.

Susa, Michiro, Lara Milane, Mansoor M. Amiji, Francis J. Hornicek, & Zhenfeng Duan. (2010). Nanoparticles: A Promising Modality in the Treatment of Sarcomas. Pharmaceutical Research. 28(2). 260–272. 14 indexed citations

20.

Milane, Lara, Zhenfeng Duan, & Mansoor M. Amiji. (2010). Development of EGFR-Targeted Polymer Blend Nanocarriers for Combination Paclitaxel/Lonidamine Delivery To Treat Multi-Drug Resistance in Human Breast and Ovarian Tumor Cells. Molecular Pharmaceutics. 8(1). 185–203. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact